Cansortium Inc
FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Flue… Read more
Market Cap & Net Worth: Cansortium Inc (CNTMF)
Cansortium Inc (OTCQB:CNTMF) has a market capitalization of $35.54 Million ($35.54 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #24988 globally and #8575 in its home market, demonstrating a -4.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cansortium Inc's stock price $0.06 by its total outstanding shares 612839992 (612.84 Million).
Cansortium Inc Market Cap History: 2025 to 2025
Cansortium Inc's market capitalization history from 2025 to 2025. Data shows growth from $35.54 Million to $35.54 Million (0.00% CAGR).
Cansortium Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cansortium Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CNTMF by Market Capitalization
Companies near Cansortium Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Cansortium Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cansortium Inc Historical Marketcap From 2025 to 2025
Between 2025 and today, Cansortium Inc's market cap moved from $35.54 Million to $ 35.54 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $35.54 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Cansortium Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.54 Million USD |
| MoneyControl | $35.54 Million USD |
| MarketWatch | $35.54 Million USD |
| marketcap.company | $35.54 Million USD |
| Reuters | $35.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.